I need OXY to really take offrising inflation will continue to hawkish stance of the fed, more rates to be raise imo. Plus oil going up.
I need OXY to really take offrising inflation will continue to hawkish stance of the fed, more rates to be raise imo. Plus oil going up.
I like oxy med to long term. Berkshire Hathaway has record cash reserve so I’m wondering if that’s for oxy. Jmo.I need OXY to really take off
I’m ready to go in raw on these diabetes weight loss drugs .
5 years from now I can be a very wealth man.
Their revenue grew by 82% yoy.$HIMS w/ the revenue and EPS beat, and announced they’re getting into wright loss drugs soon.
Hims & Hers weight loss business to launch by end of 2023
Hims & Hers to enter into lucrative weight loss market.www.aol.com
Up 16%Eli Lilly raises full-year guidance as Mounjaro, other drugs drive second-quarter profit up 85%
Eli Lilly's stock has been on a tear, driven by positive trial results for its Alzheimer's drug and progress with its promising obesity drug pipeline.www.cnbc.com
Up 9% in pm
Their revenue grew by 82% yoy.
I might start watching this again.
They have a unique marketing platform that is “very trendy”.
I’m thinking short to mid term bearish. Just my assessment at this moment,imo. Cost of borrowing is up a lot and the effects of that hasn’t even hit the books yet.
From June.MRNA seems like a nice short. JMO.
How much of that will be negated by stock based competition diluting shareholders?Palantir announced $1B buyback.
Not sure. SBC is trending down tho.How much of that will be negated by stock based competition diluting shareholders?